PK

Pushpak Kumar Thakur

Active Director Additional Director DIN 10781706
DIN 10781706 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Pushpak Kumar Thakur

Data last updated:

Pushpak Kumar Thakur is an Additional Director at Glenspoke Pharmaceuticals India Private Limited (since 2024). The company operates in Pharma.

DIN 10781706
Primary Designation Additional Director
Industry Pharma
First Appointment 21 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director21 Sep 20242024Active

Board colleagues of Pushpak Kumar Thakur

Directorship timeline

Open interactive timeline →
Glenspoke Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Pushpak Kumar Thakur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pushpak Kumar Thakur

Pushpak Kumar Thakur currently holds 1 directorship: Glenspoke Pharmaceuticals India Private Limited (Additional Director, since 21 Sep 2024).

Pushpak Kumar Thakur was first appointed on 21 Sep 2024 as Additional Director at Glenspoke Pharmaceuticals India Private Limited.

The current boards of Pushpak Kumar Thakur's companies include Jay Prakash Yadav (Glenspoke Pharmaceuticals India Private Limited), Yuvraj Kumar (Glenspoke Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available